The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. SMA Europe awards new research grants through its 8th call for research proposals

    1868-200SMA research receives vital funds from SMA Europe. Based on the recommendations received by its Scientific Advisory Board, SMA Europe awarded a total of 473,000 Euros to 5 cutting-edge SMA research projects through its 8th Call for Research Proposals.

    The Scientific Advisory Board reviewed and scored 18 very high level SMA research proposals. As only 26% could be funded, hard decisions had to be made and the following 5 were recommended for funding:

    • Determining the temporal, spatial and molecular signature of hypoxia in spinal muscular atrophy  – Professor Simon Parson – 109,293 EUR over 2 years – University of Aberdeen, UK.
    • Seeking small molecules that stabilise protein RNA interactions to cure Spinal Muscular Atrophy – Professor Frédéric Allain – 150,000 Euros over 2 years – ETH Zurich – Switzerland.
    • Regulation of the Survival Motor Neuron (SMN) protein by acetylation and its importance in snRNP biogenesis and molecular assembly of cajal bodies  – Dr. Olga Tapia – ~40,000 Euros over 1 year – University of Cantabria, Spain.
    • The ROCK-ERK signalling network in SMA – mediator of neurodegeneration and SMN independent treatment target – Dr. Niko Hensel – 100,000 Euros over 2 years – Hannover Medical School – Germany.
    • Role of a redox sensor in nuclear organisation and its implication in spinal muscular atrophy – Dr. Suzie Lefebvre – 73,000 Euros over 2 years – Université Paris Descartes, France

    SMA Europe looks forward to the initiation of these projects.